2018
DOI: 10.1002/jbt.22190
|View full text |Cite
|
Sign up to set email alerts
|

Study on the potential way of hepatic cytotoxicity of N,N‐dimethylformamide

Abstract: The intermediate metabolites and redox status imbalance were supported as the two major points for N,N-dimethylformamide (DMF)-induced hepatotoxicity. However, the potential mechanism has not yet been concerned. By applying two inhibitors, this study tried to seek the major role in DMF-induced toxicity on HL7702 cell. We observed that DMF induced cell apoptosis through mitochondrial-dependent and p53 pathway. Inhibition reactive oxygen species by catalase remarkably attenuated the mitochondrial transmembrane p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 31 publications
2
3
0
Order By: Relevance
“…Similarly, the Group 1 carcinogen trichloroethylene (79-01-6) enriched Prostate Cancer, Hepatocellular Carcinoma, and four similar pathways, which is consistent with epidemiological studies that linked this chemical to liver and prostate cancer in humans with significant exposures . The Group 2A carcinogen dimethylformamide (68-12-2) induces apoptosis in liver cells through the p53 pathway and maintains a redox status imbalance . Consistent with these findings, dimethylformamide enriched 13 apoptosis-related pathways (e.g., Apoptosis), 16 TP53/p53-related pathways (e.g., p53 Pathway), and oxidative stress pathways (e.g., Oxidative Stress Induced Senescence).…”
Section: Discussionsupporting
confidence: 77%
See 1 more Smart Citation
“…Similarly, the Group 1 carcinogen trichloroethylene (79-01-6) enriched Prostate Cancer, Hepatocellular Carcinoma, and four similar pathways, which is consistent with epidemiological studies that linked this chemical to liver and prostate cancer in humans with significant exposures . The Group 2A carcinogen dimethylformamide (68-12-2) induces apoptosis in liver cells through the p53 pathway and maintains a redox status imbalance . Consistent with these findings, dimethylformamide enriched 13 apoptosis-related pathways (e.g., Apoptosis), 16 TP53/p53-related pathways (e.g., p53 Pathway), and oxidative stress pathways (e.g., Oxidative Stress Induced Senescence).…”
Section: Discussionsupporting
confidence: 77%
“… 58 The Group 2A carcinogen dimethylformamide (68-12-2) induces apoptosis in liver cells through the p53 pathway and maintains a redox status imbalance. 59 Consistent with these findings, dimethylformamide enriched 13 apoptosis-related pathways (e.g., Apoptosis), 16 TP53/p53-related pathways (e.g., p53 Pathway), and oxidative stress pathways (e.g., Oxidative Stress Induced Senescence).…”
Section: Discussionsupporting
confidence: 56%
“…Changes in MMP were measured using the MMP assay kit with JC-1(Beyotime Biotechnology, Shanghai, China) as described previously [19].…”
Section: Measurement Of Mitochondrial Membrane Potential (Mmp)mentioning
confidence: 99%
“…Previous studies have indicated that overdose of DMF causes hepatic cytotoxicity, 39 , 40 which leads to the consideration of choosing the appropriate dose for disease treatment. Moreover, DMF is known to elicit certain alcohol intolerance reactions.…”
Section: Discussionmentioning
confidence: 99%